共 50 条
- [21] RETRACTED: APROTININ USE IN PEDIATRIC CARDIAC OPERATIONS - REPLY (Retracted article. See vol. 161, pg. 1562, 2021) [J]. JOURNAL OF THORACIC AND CARDIOVASCULAR SURGERY, 1993, 105 (04): : 759 - 760
- [24] CELL-MEDIATED-IMMUNITY AFTER CARDIAC OPERATIONS - REPLY [J]. JOURNAL OF THORACIC AND CARDIOVASCULAR SURGERY, 1991, 101 (02): : 362 - 362
- [25] Methylene Blue for Vasoplegic Syndrome After Cardiac Operations Reply [J]. ANNALS OF THORACIC SURGERY, 2019, 107 (02): : 686 - 686
- [26] Methylene blue administration in SIRS after cardiac operations - Reply [J]. ANNALS OF THORACIC SURGERY, 1997, 63 (04): : 1213 - 1213
- [27] Hematologic and economic impact of aprotinin in reoperative pediatric cardiac operations [J]. ANNALS OF THORACIC SURGERY, 1998, 66 (02): : 535 - 540
- [28] Tranexamic Acid and Aprotinin in Primary Cardiac Operations: An Analysis of 220 Cardiac Surgical Patients Treated with Tranexamic Acid or Aprotinin [J]. ANESTHESIA AND ANALGESIA, 2008, 107 (05): : 1469 - 1478
- [29] TOPICAL USE OF APROTININ IN OPEN-HEART OPERATIONS [J]. ANNALS OF THORACIC SURGERY, 1993, 55 (03): : 658 - 661
- [30] TOPICAL USE OF APROTININ IN CARDIAC-SURGERY [J]. JOURNAL OF THORACIC AND CARDIOVASCULAR SURGERY, 1995, 110 (02): : 568 - 569